Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oleksandr Sverdlov

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Statistics in Medicine|June 6, 2018
A comparative study of restricted randomization procedures for multiarm trials with equal or unequal treatment allocation ratiosYevgen Ryeznik, Oleksandr Sverdlov
Statistics in Medicine|May 4, 2019
Implementing unequal randomization in clinical trials with heterogeneous treatment costsOleksandr Sverdlov, Yevgen Ryeznik
Therapeutic Innovation & Regulatory Science|September 21, 2018
Novel Statistical Designs for Phase I/II and Phase II Clinical Trials With Dose-Finding ObjectivesOleksandr Sverdlov, Weng Kee Wong
Frontiers in Digital Health|February 26, 2025
Designing and developing a prescription digital therapeutic for at-home heart rate variability biofeedback to support and enhance patient outcomes in post-traumatic stress disorder treatmentRebecca Macy, Flavio Somanji, Oleksandr Sverdlov
Therapeutic Innovation & Regulatory Science|September 18, 2018
Exact Bayesian Inference Comparing Binomial Proportions, With Application to Proof-of-Concept Clinical TrialsOleksandr Sverdlov, Yevgen Ryeznik, Sheng Wu
The AAPS Journal|July 21, 2018
Implementing Optimal Designs for Dose-Response Studies Through Adaptive Randomization for a Small Population GroupYevgen Ryeznik, Oleksandr Sverdlov, Andrew C Hooker
Journal of Biopharmaceutical Statistics|June 2, 2012
Adaptive randomization for clinical trialsWilliam F Rosenberger, Oleksandr Sverdlov, Feifang Hu
Contemporary Clinical Trials|April 12, 2021
Opportunity for efficiency in clinical development: An overview of adaptive clinical trial designs and innovative machine learning tools, with examples from the cardiovascular fieldOleksandr Sverdlov, Yevgen Ryeznik, Weng Kee Wong
Statistics in Medicine|August 9, 2011
Optimal response-adaptive randomized designs for multi-armed survival trialsOleksandr Sverdlov, Yevgen Tymofyeyev, Weng Kee Wong
Pharmaceutical Statistics|January 14, 2024
On "Re-randomization tests as sensitivity analyses to confirm immunological noninferiority of an investigational vaccine: Case study" by Luca Grassano et al. (2023, Pharmaceutical Statistics)Oleksandr Sverdlov, Vance W Berger, Kerstine Carter
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Statistics in Medicine|June 6, 2018
A comparative study of restricted randomization procedures for multiarm trials with equal or unequal treatment allocation ratiosYevgen Ryeznik, Oleksandr Sverdlov
Statistics in Medicine|May 4, 2019
Implementing unequal randomization in clinical trials with heterogeneous treatment costsOleksandr Sverdlov, Yevgen Ryeznik
Therapeutic Innovation & Regulatory Science|September 21, 2018
Novel Statistical Designs for Phase I/II and Phase II Clinical Trials With Dose-Finding ObjectivesOleksandr Sverdlov, Weng Kee Wong
Frontiers in Digital Health|February 26, 2025
Designing and developing a prescription digital therapeutic for at-home heart rate variability biofeedback to support and enhance patient outcomes in post-traumatic stress disorder treatmentRebecca Macy, Flavio Somanji, Oleksandr Sverdlov
Therapeutic Innovation & Regulatory Science|September 18, 2018
Exact Bayesian Inference Comparing Binomial Proportions, With Application to Proof-of-Concept Clinical TrialsOleksandr Sverdlov, Yevgen Ryeznik, Sheng Wu
The AAPS Journal|July 21, 2018
Implementing Optimal Designs for Dose-Response Studies Through Adaptive Randomization for a Small Population GroupYevgen Ryeznik, Oleksandr Sverdlov, Andrew C Hooker
Journal of Biopharmaceutical Statistics|June 2, 2012
Adaptive randomization for clinical trialsWilliam F Rosenberger, Oleksandr Sverdlov, Feifang Hu
Contemporary Clinical Trials|April 12, 2021
Opportunity for efficiency in clinical development: An overview of adaptive clinical trial designs and innovative machine learning tools, with examples from the cardiovascular fieldOleksandr Sverdlov, Yevgen Ryeznik, Weng Kee Wong
Statistics in Medicine|August 9, 2011
Optimal response-adaptive randomized designs for multi-armed survival trialsOleksandr Sverdlov, Yevgen Tymofyeyev, Weng Kee Wong
Pharmaceutical Statistics|January 14, 2024
On "Re-randomization tests as sensitivity analyses to confirm immunological noninferiority of an investigational vaccine: Case study" by Luca Grassano et al. (2023, Pharmaceutical Statistics)Oleksandr Sverdlov, Vance W Berger, Kerstine Carter
Pageof 5